391668-75-0 Usage
Uses
Used in Pharmaceutical Research:
6-FORMYL-2,3-DIHYDRO-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER is used as a key intermediate in the synthesis of pharmaceutical compounds for various therapeutic applications. Its unique structure allows for the development of new drugs with novel mechanisms of action and improved pharmacological properties.
Used in Organic Synthesis:
In the field of organic synthesis, 6-FORMYL-2,3-DIHYDRO-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER serves as a versatile building block for the creation of complex organic molecules. Its reactivity and functional groups enable the formation of a wide range of chemical products, including natural products, agrochemicals, and specialty chemicals.
Used in Medicinal Chemistry:
6-FORMYL-2,3-DIHYDRO-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER is utilized as a valuable tool in medicinal chemistry for the design and optimization of drug candidates. Its structural features facilitate the exploration of new chemical space and the identification of potential lead compounds with improved potency, selectivity, and pharmacokinetic properties.
Used in Drug Discovery:
In drug discovery efforts, 6-FORMYL-2,3-DIHYDRO-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER plays a crucial role in the identification and optimization of novel bioactive molecules. Its unique properties and ease of synthesis make it an attractive starting point for the development of new therapeutic agents targeting various diseases and conditions.
Used in Chemical Research:
6-FORMYL-2,3-DIHYDRO-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER is employed as a research chemical in academic and industrial settings to study the fundamental aspects of chemical reactions and mechanisms. Its unique reactivity and structural features provide insights into the underlying principles of organic chemistry and contribute to the advancement of chemical knowledge.
Used in Industrial Applications:
6-FORMYL-2,3-DIHYDRO-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER finds applications in various industrial processes, including the production of specialty chemicals, agrochemicals, and materials. Its versatility and ease of synthesis make it a valuable component in the development of innovative products and technologies across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 391668-75-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,9,1,6,6 and 8 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 391668-75:
(8*3)+(7*9)+(6*1)+(5*6)+(4*6)+(3*8)+(2*7)+(1*5)=190
190 % 10 = 0
So 391668-75-0 is a valid CAS Registry Number.
391668-75-0Relevant academic research and scientific papers
RING-FUSED COMPOUND
-
Paragraph 0515-0516; 0593-0594, (2014/01/07)
The present invention relates to a compound that has URAT1 inhibitory action, and a URAT1 inhibitor, a blood uric acid level-reducing agent and a pharmaceutical composition comprising the compound. More specifically, the present invention relates to a compound represented by Formula (I) below. [in the formula, R1 is -Q1-A1 and the like; ---- is a double bond or a single bond; when ---- is a double bond, W1 is a nitrogen atom or a group represented by the general formula: =C(Ra)-, and W2 is a nitrogen atom or a group represented by the general formula: =C(Rb) -; when ---- is a single bond, W1 is a group represented by the general formula: -C(Raa)(Rab)- or a group represented by the general formula: -(C=O) -, and W2 is a group represented by the general formula: C(Rba)(Rbb)-, a group represented by the general formula: - (C=O) - or a group represented by the general formula: -N(Rbc)-; W3, W4 and W5 are each independently a nitrogen atom or a methine group and the like that may have a substituent; X is a single bond, an oxygen atom and the like; Y is a single bond or (CRYiRYi')n; and Z is a hydroxyl group or COOR2 and the like.
NOVEL CURCUMIN DERIVATIVE
-
Page/Page column 80, (2009/12/07)
The present invention provides a novel compound that is structurally similar to curcumin and has a suppressive effect on Aβ aggregation, a degradative effect on Aβ aggregates, an inhibitory effect on β-secretase, and a protective effect on neurons. The novel compound is a compound represented by the following general formula (Ia) or a salt thereof: wherein R1 represents a 4-hydroxy-3-methoxyphenyl group or the like, and R2 represents a 1H-indol-6-yl group or the like.
Medicine comprising dicyanopyridine derivative
-
Page 20, (2010/02/06)
Compounds having a high conductance-type of calcium-activated K channel opening effect and a smooth muscle relaxant effect for bladder based on the K-channel opening effect, which can be used in treating pollakiuria and urinary incontinence, are provided.
